ACADIA PHARMACEUTICALS INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-289.4M | $-271.4M | $-164.4M | $-92.5M | $-37.9M | $-20.8M | $-22.8M | $15.1M |
| Depreciation & Amortization | — | — | — | $206.0K | $79.0K | $109.0K | $285.0K | — |
| Depreciation | $1.2M | $843.0K | $647.0K | $206.0K | $79.0K | $109.0K | $285.0K | $607.0K |
| Amortization | $1.5M | $985.0K | $0 | $0 | — | — | — | — |
| Stock-Based Compensation | $75.5M | $55.3M | $40.2M | $16.0M | $5.7M | $1.9M | $1.6M | $1.6M |
| Net Cash from Operating Activities | $-217.8M | $-208.4M | $-121.8M | $-66.4M | $-31.8M | $-21.6M | $-19.9M | $-10.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $812.0K | $1.5M | $2.1M | $180.0K | $618.0K | — | $3.0K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $92.5M | $-261.9M | — | — | — | $-25.5M | $6.0M | $-1.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $31.2M | $533.8M | — | — | — | $98.2M | $13.9M | $470.0K |
| Net Change in Cash | $-94.2M | $61.5M | $40.3M | $50.1M | $-46.2M | $51.0M | $40.0K | $-11.3M |
| Free Cash Flow | $-218.6M | $-209.9M | $-123.9M | $-66.6M | $-32.4M | — | $-19.9M | — |